InMed gets Nasdaq notice after stockholders’ equity falls below $2.5 million minimum

InMed received a Nasdaq notice for failing the $2.5 million minimum stockholders’ equity requirement in its fiscal 2026 Form 10-K.

• Stockholders’ equity was $1,075,007, putting the company at risk of delisting from the Nasdaq Capital Market.
• Nasdaq gave InMed 45 days to submit a compliance plan; an accepted plan could secure up to a 180-day extension.
• Management expects the Mentari merger and related pre-closing financing to restore compliance, with about $490 million in gross proceeds anticipated.
• If compliance is not regained, Nasdaq could move to delist; an appeal would keep shares trading pending a hearings process.